Discovery and structure–activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors
John R. Boot, Manuel Cases, Barry P. Clark et al. · Bioorganic & Medicinal Chemistry Letters · 2004
Cited by 30 works. doi:10.1016/j.bmcl.2004.11.025
Authors
- John R. Boot
- Manuel Cases
- Barry P. Clark
- Jeremy D. Findlay
- P. T. Gallagher
- Lorna Hayhurst
- Teresa Man
- Christian Montalbetti
- Richard E. Rathmell
- Hélène Rudyk
- Magnus W. Walter
- Maria Ann Whatton
- Virginia A. Wood
References
- Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
- 1,1′-(azodicarbonyl)dipiperidine-tributylphosphine, a new reagent system for mitsunobu reaction
- Prior Antipsychotic Prescribing in Patients Currently Receiving Clozapine
- Phosphorylation and Regulation of Antidepressant-sensitive Serotonin Transporters
- Tests of a piperidino mask for the protection of functionalized carbon sites in multistep syntheses
- Development of scintillation-proximity assays for alpha adrenoceptors
- New approaches to developing antidepressants by enhancing monoaminergic neurotransmission
- Reboxetine: A Selective Norepinephrine Reuptake Inhibitor for the Treatment of Depression
- Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake
- Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.